Safety and Prognostic Value of Left Ventricular Endomyocardial Biopsy in Dilated Cardiomyopathy
Left ventricular EMB is a safe diagnostic procedure. The extent of CVF in LV-EMB provides prognostic information in patients with DCM in addition to existing measures of left ventricular ejection fraction or NT-proBNP.
Authors
- Bernd Lahrmann
- Ali Amr (ORCID: https://orcid.org/0000-0002-2615-4089)
- Lutz Frankenstein (ORCID: https://orcid.org/0000-0001-7216-1004)
- Norbert Frey (ORCID: https://orcid.org/0000-0001-7611-378X)
- Daniel Tian Li
- Benjamin Meder (ORCID: https://orcid.org/0000-0003-0741-2633)
- Niels Grabe (ORCID: https://orcid.org/0000-0003-1732-3706)
- Christoph Reich (ORCID: https://orcid.org/0000-0002-2683-1369)
- Farbod Sedaghat‐Hamedani (ORCID: https://orcid.org/0000-0002-3266-0527)
- Esther Herpel (ORCID: https://orcid.org/0000-0002-0110-9257)
- Derliz Mereles (ORCID: https://orcid.org/0000-0001-9601-7103)
- Elham Kayvanpour (ORCID: https://orcid.org/0000-0001-7285-2825)
- Chenyang Wang (ORCID: https://orcid.org/0000-0002-3039-0615)
- Alan Lai (ORCID: https://orcid.org/0000-0003-0916-9227)
- E. Amr
- H. A. Katus
Institutions
- Roche (United States) (US)
- Heidelberg University (DE)
- Roche Pharma AG (Germany) (DE)
- Klinikum Darmstadt (DE)
- National Center for Tumor Diseases (DE)
- Universitätsmedizin Göttingen (DE)
- German Centre for Cardiovascular Research (DE)
- Stanford Medicine (US)
- CS Diagnostics (DE)
- Hamamatsu Medical Center (JP)
- University of Göttingen (DE)
- Heidelberg University (US)
- Stanford University (US)
Publication Details
- Journal
- European Journal of Heart Failure
- Published
- 2025-09-19
- DOI
- https://doi.org/10.1002/ejhf.70019
- Citations
- 1
- Primary Topic
- Viral Infections and Immunology Research
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- Deutsches Zentrum für Herz-Kreislaufforschung
- Bundesministerium für Bildung und Forschung